Agf Investments Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Agf Investments Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$595.12 - $698.43 $583,812 - $685,159	-981 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$543.48 - $670.97 $253,805 - $313,342	-467 Reduced 32.25%	981 $620,000
Q3 2021 Nov 10, 2021	BUY	$574.03 - $680.96 $204,928 - $243,102	357 Added 32.72%	1,448 $876,000
Q2 2021 Aug 10, 2021	BUY	$472.8 - $558.54 $339,943 - $401,590	719 Added 193.28%	1,091 $609,000
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $11,614 - $14,253	26 Added 7.51%	372 $176,000
Q4 2020 Feb 08, 2021	SELL	$478.3 - $607.98 $108,574 - $138,011	-227 Reduced 39.62%	346 $167,000
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $417,823 - $504,847	-767 Reduced 57.24%	573 $321,000
Q2 2020 Aug 11, 2020	SELL	$493.32 - $643.92 $158,849 - $207,342	-322 Reduced 19.37%	1,340 $836,000
Q1 2020 May 08, 2020	BUY	$336.18 - $494.43 $558,731 - $821,742	1,662 New	1,662 $812,000
Q4 2017 Feb 07, 2018	SELL	$358.63 - $469.95 $24.6 Million - $32.2 Million	-68,486 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$431.38 - $504.0 $29.5 Million - $34.5 Million	68,486	68,486 $30.6 Million

1,532

83.6M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $78.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.